Overall rank by patents
#45,924
of 49,997 tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, recorded in grant years 2020–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61G (Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices).
The verdict
According to USPTO PatentsView, Creative ranks #45,924 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 4 technology areas.
USPTO PatentsView assignee plate
Corpus R45924 · US Corporation #45,924 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-PAR · TYPE-USCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Crativ Solutions, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Creative Medical… · this assignee
20 score
3D Lighting… · lowest
7 score
What this shows Creative's Innovation Score is 19.6/100 (6th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Creative Medical Devices LLC is a focused PatentsView assignee: 4 CPC subclasses with 60% of grants classified under A61G (Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices). Peak complete grant year is 2020 (3 grants) versus a trough of 2 in 2021. By volume, Creative sits between Crativ Solutions, Inc. and Croma-pharma GMBH.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Crativ Solutions, Inc.
5 patents
Crayonano AS
5 patents
Crealyst-group
5 patents
Creative Extruded Products, Inc.
5 patents
Creative Mobile Technologies LLC
5 patents
CRH Medical Corporation
5 patents
Cristalfarma S.R.L.
5 patents
Croma-pharma GMBH
5 patents
Creative Medical Devices LLC
5 patents
What this shows Creative holds 5 patents at rank #45,663, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #45,663 in granted patent volume.
Other assignees with the most granted patents in Creative's primary technology class.
Creative's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
20 6th percentile higher than 6% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 3 | 60.0% |
| 2021 | 2 | 40.0% |
Top 4 of 4 technology areas
Overall rank by patents
#45,924
of 49,997 tracked assignees
19.6 out of 100
What to do with this data
Creative Medical Devices LLC's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.